Ingredientes Ómega-3 da Ásia-Pacífico para o Mercado Farmacêutico – Tendências da Indústria e Previsão para 2030

Ingredientes ómega-3 da Ásia-Pacífico para análise e tamanho do mercado farmacêutico

Prevê-se que a inclinação da preferência dos consumidores por uma dieta saudável composta por ingredientes ómega-3 e a utilização generalizada de óleo de peixe no Sudeste Asiático melhorem as vendas de ómega-3 na região Ásia-Pacífico. Estão actualmente a ser realizados numerosos estudos de investigação que deverão criar uma vantagem competitiva para vários fabricantes desenvolverem novos e inovadores ingredientes ómega-3 para produtos farmacêuticos. O aumento do estilo de vida e das doenças relacionadas com a idade na Ásia-Pacífico está, consequentemente, a melhorar o crescimento do segmento dos suplementos e alimentos funcionais , com uma quota de receitas de 52%.

A Data Bridge Market Research analisa uma taxa de crescimento no mercado de ingredientes ómega-3 para produtos farmacêuticos no período de previsão 2023-2030. O CAGR esperado dos ingredientes ómega-3 para o mercado farmacêutico é de cerca de 12,5% no período de previsão mencionado. O mercado está avaliado em 115,5 milhões de dólares em 2022 e cresceria até 296,35 milhões de dólares até 2030. Para além dos insights de mercado, como o valor de mercado, taxa de crescimento, segmentos de mercado, cobertura geográfica, participantes no mercado e cenário de mercado, o O relatório de mercado com curadoria da equipa de pesquisa de mercado da Data Bridge inclui também uma análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Ingredientes ómega-3 da Ásia-Pacífico para o âmbito e segmentação do mercado farmacêutico

Market Definition

Omega 3 ingredients are naturally occurring polyunsaturated fatty acids and nutrients that are essential for optimal human health. There are three kinds of omega 3 ingredients, namely, eicosapentaenoic acid (EPA), alpha-linoleic acid (ALA), and docosahexaenoic acid (DHA). EPA and DHA are mostly extracted from fish and ALA is mainly extracted from plants sources such as seeds and nuts.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Dynamics

Drivers

• Increasing Demand of Infants Formula

This growing demand for infant nutrition is boosting the omega-3 market in Asia-Pacific region. China and India are the world’s largest consumers of infant formula products because of high birth rates in the countries. In 2015, China resulted for about one-third of the infant formula market, while infant formula is also the largest segment of baby food in India, where an annual average of childbirth is more than 25 million children. The growing demand for high-nutritional food for infants in the developed and developing economies of Asia, such as China and India led to the further increase in the consumption of omega-3 products which in turn is estimated to increase the growth in the region. Thus, this factor increases the growth of the market.

• Rising Technological Advancements

Technological advancements and product innovation is anticipated to boost the market for omega 3 ingredients during the forecast period. For instance, DSM introduced new 3C technology to reinvigorate omega 3 supplements category on October 6, 2016. Furthermore, on June 9, 2015, Croda introduced Incromega DHA and approved by European Food Safety Authority (EFSA). Additionally, Royal DSM collaborated with Evonik to manufacture omega 3 fatty acid products from natural marine algae for animal nutrition on March 8, 2017. This innovation will allow the production of omega 3 fatty acids for animal nutrition without using fish oil. This factor improves the market growth.

Opportunities

• Huge growth in concentrated forms of algal omega-3 ingredients

New ultra-high concentrated omega-3 ingredients offer several benefits to consumers willing to pay a higher premium price for high-end products. Several suppliers are investing in the production of high concentrated algal omega-3 products, estimating increased demand to drive the sales. The market for concentrates has also been increasing, as more consumers become aware of the benefits of algal omega-3 and seek the benefits of higher doses. Several major companies are involved in omega-3 manufacturing that has started to strategically capitalize the existing business expansion opportunity.

• Rising Demand of Omega-3 by Elderly Population

There is an increasing focus on healthy aging with good physical and mental function that is boosting the growth of the market. Countries, such as Japan, are experiencing a "super-aging" society in rural and urban areas. As per the 2014 estimates by Bloomberg, around 33.0% of the Japanese population was above the age of 60, 25.9% were aged 65 or above, and 12.5% were aged 75 or above. Increased blood levels of omega-3 fatty acids found in seafood are related with a higher likelihood of healthy aging among older adults. This is leading the manufacturers to develop the varieties of omega-3 ingredients in bulk. Thus, this factor helps to create much opportunities for the growth of the market.

Restraints/Challenges

• Side Effects of omega-3 ingredients

There are various side-effects associated with the omega-3 ingredients for pharmaceuticals. Effects such as burping, diarrhea, heartburn, joint pain, stomach pain or discomfort, vomiting, constipation, nausea. Thus, these adverse effects affect the growth rate by decreasing the adoption of omega-3. This impedes the market growth.

• Increasing Negative Consumer Perception About omega-3 ingredients

Negative consumer perception associated with the smell and taste of omega-3 ingredients is also anticipated to limit the growth of the market. These unstable fatty acids can damage through enzymatic or chemical oxidation to form compounds that give foods a fishy smell. Additionally, fresh fish oil has no fishy taste or smell, just like fresh fish. People feel hesitant to adopt for omega-3 ingredients. Thus, this hampers the market growth.

This omega-3 ingredients for pharmaceuticals market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the omega-3 ingredients for pharmaceuticals market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In 2021, Omega-3 related supplier GC Rieber VivoMega announced its plans to enhance production facilities and storage tanks to accommodate more ingredients in the upcoming years.
• In 2020, DSM launched a plant-based DHA oil product, DHA SF55-O200DS oil extracted from schizochytrium algae. This product is utilized for enhancing the nutrition in mothers and infants. This new product launch by DSM increased its product portfolio in nutrition business thus, increased demand for its product in the market causes increased revenue in future.

Asia-Pacific Omega-3 Ingredients for Pharmaceuticals Market Scope

The Omega-3 ingredients for pharmaceuticals market is segmented on the basis of source, type, forms, therapeutic areas, population type, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Source

• Marine
• Plant

Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-Linolenic Acid (ALA)

Forms

• Liquid
• Dry

Therapeutic Areas

• Cardiovascular Diseases
• Autoimmune Diseases
• Bone & Joint Disorders
• Neurological Disorders
• Ophthalmic Disorders
• Skin Health
• Cancer
• Others

Population Type

• Adults
• Children

Distribution Channel

• Direct
• Indirect

Omega-3 Ingredients for Pharmaceuticals Market Regional Analysis/Insights

The Omega-3 ingredients for pharmaceuticals market is analyzed and market size insights and trends are provided by source, type, forms, therapeutic areas, population type, and distribution channel as referenced above.

The major countries covered in the Omega-3 ingredients for pharmaceuticals market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

A China lidera o mercado devido ao aumento da procura dos consumidores por produtos ómega-3 à base de plantas. Espera-se que a crescente importância do ómega 3 DHA para o desenvolvimento do sistema nervoso, visão e cérebro infantil, combinada com a capacidade do produto de apoiar a saúde a longo prazo, impulsione o crescimento do mercado nos próximos anos.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Além disso, são considerados a presença e disponibilidade de marcas da Ásia-Pacífico e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas domésticas e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Cenário competitivo e ingredientes ómega-3 da Ásia-Pacífico para análise da quota de mercado farmacêutico

O cenário competitivo dos ingredientes ómega-3 para o mercado farmacêutico fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na Ásia-Pacífico, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento de produtos, largura e amplitude do produto , dominância da aplicação. Os dados fornecidos acima estão apenas relacionados com o foco das empresas em relação aos ingredientes Ómega-3 para o mercado farmacêutico.

Os principais players que trabalham no mercado de Ingredientes ómega-3 para produtos farmacêuticos incluem:

• Avestia Pharma (Índia)
• Novasep (França)
• (EUA)
• Grupo KD Pharma (Japão)
• BASF SE (Alemanha))
• Corbion (Holanda)
• DSM (Holanda)
• AstraZeneca (Reino Unido)
• A GSK plc. (REINO UNIDO)
• Fresenius Kabi AG (Alemanha)
• Croda International Plc (EUA)
• AMARIN CORPORATION (Irlanda)
• (EUA)
• Epax (Noruega)
• Strides Pharma Science Limited (Índia)
• Pharma Marine AS (Noruega)
• (China)
• Camber Pharmaceuticals, Inc.

SKU-55583